Group 1 - Stanford University and Elsevier published the 2025 "Top 2% Global Scientists" list, recognizing the top 2% of scholars from nearly 7 million researchers worldwide [1] - Professor He Xiaoshun, Director of the Organ Transplant Center at Sun Yat-sen University First Affiliated Hospital, was honored on this list and is also the founder and chief scientist of Singularity Medical Technology [2] Group 2 - Professor He Xiaoshun is a pioneer in organ medicine, having performed the world's first non-ischemic liver transplant in 2017 and introduced the concept of "organ medicine" in 2019 [3] - The "Domino-Extracorporeal Liver Support Therapy" developed by his team provides new hope for critically ill patients who cannot undergo transplantation [3] - The "extracorporeal liver" technology allows for the maintenance of non-transplantable but functional livers, providing essential liver function support to patients in need [3] Group 3 - Singularity Medical, established in May 2020, focuses on organ medicine research and development, with a pipeline covering organ transplantation, donation, isolation treatment, and new drug development [4] - The company has achieved significant milestones, including the world's first vascular intervention for liver cancer isolation treatment and the revival of a pig brain after 50 minutes of death [4] - The company has a strong R&D team, with 51% of its workforce dedicated to research, and has filed 61 patents, with 44 granted [4] Group 4 - Singularity Medical's first innovative medical device, the "Liver Perfusion System," has entered the special review process by the National Medical Products Administration, with full case enrollment expected by October 2025 and registration anticipated by 2027 [4] - Another core product, the "Donor Perfusion System," received approval for special review in June 2025, with efforts underway to expedite clinical trials [4]

Core Insights - The article highlights the upcoming global medical technology conferences scheduled for 2025, including the first Global Aesthetic Technology Conference and the second Global Medical Technology Conference [1][15] - It discusses the recent approval of six innovative medical devices by NMPA, indicating a growing focus on advanced medical technologies in China [1] Company Summaries - **Dunbo Medical**: A high-tech company specializing in the research and production of Class III active implantable medical devices, including single-chamber and dual-chamber wireless pacemakers, and vagus nerve stimulators for heart failure [2] - **Aikang Yicheng Medical**: Established in 2003, this company focuses on spinal fixation systems and has multiple national-level research and development platforms, including a postdoctoral research workstation [3] - **Jiangsu Raman Medical Equipment**: This company specializes in Raman optical biopsy technology, providing real-time optical biopsy solutions for various medical fields, enhancing surgical efficiency and diagnostic accuracy [5] - **Singularity Medical Technology**: Engaged in organ medicine and industrial development, this company has developed a non-ischemic liver perfusion system that significantly improves transplant outcomes by maintaining organ function during transport [8] - **Shanghai United Imaging Healthcare**: Founded in 2011, this company focuses on high-end medical imaging equipment and has a comprehensive product line that includes MRI, CT, and PET/CT systems [9][11] - **Shanghai Pangying Technology**: An innovative medical technology company that has developed the Hairo hair transplant robot, providing a comprehensive solution for hair restoration with advanced visual recognition and precision control [12][14]